RxSight (RXST) Stock Statistics & Valuation Metrics

RxSight has a market cap or net worth of $570.11M. The enterprise value is $1.16B.

RxSight has 40.49M shares outstanding. The number of shares has decreased by -2.65% in one year.

RxSight’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is -12.57%.

The current PE Ratio of RxSight is -48.67. RxSight’s PEG ratio is 0.98.

In the last 12 months, RxSight had revenue of $150.02M and earned -$27.45M in profits. Earnings per share was -$0.72.

In the last 12 months, operating cash flow was -$17.03M and capital expenditures -$5.44M, giving a free cash flow of -$22.47M billion.

RxSight pays an annual dividend of , resulting in a dividend yield of

RxSight upcoming earnings date is May 7, 2025, After Close.

RxSight as a current ratio of 11.36, with Debt / Equity ratio of 0.04

In the past 12 months, RxSight has paid $50.00K in taxes.

RxSight EV to EBITDA ratio is -56.05, with an EV/FCF ratio of -59.50.

RxSight has $237.22M in cash and marketable securities with $12.30M in debt, giving a net cash position of -$224.93M billion.

Gross margin is 70.71%, with operating margin of -26.34%, and net profit margin of -19.62%.

The average price target for RxSight is $27.60, which is 11.43% higher than the current price. The consensus rating is Hold